Analysis of Safety and Tolerability Data in Pediatric Patients with Primary Immunodeficiency Diseases from Two Phase 2/3 Studies of Human Immune Globulin Subcutaneous, 20%

Kenneth Paris; Elie Haddad; Iftikhar Hussain; Nicholas Brodszki; Amy Liebl Darter; Werner Engl; Barbara McCoy; Leman Yel

doi:10.1016/j.jaci.2016.12.703

Analysis of Safety and Tolerability Data in Pediatric Patients with Primary Immunodeficiency Diseases from Two Phase 2/3 Studies of Human Immune Globulin Subcutaneous, 20%

Journal of Allergy and Clinical Immunology ◽

10.1016/j.jaci.2016.12.703 ◽

2017 ◽

Vol 139 (2) ◽

pp. AB217

Author(s):

Kenneth Paris ◽

Elie Haddad ◽

Iftikhar Hussain ◽

Nicholas Brodszki ◽

Amy Liebl Darter ◽

...

Keyword(s):

Immune Globulin ◽

Primary Immunodeficiency ◽

Pediatric Patients ◽

Phase 2 ◽

Primary Immunodeficiency Diseases ◽

Two Phase ◽

Immunodeficiency Diseases ◽

Tolerability Data ◽

Human Immune

Download Full-text

Onboarding Experience of Pediatric Patients With Primary Immunodeficiency Diseases With Subcutaneous Human Immune Globulin 20% (Ig20Gly)

Journal of Allergy and Clinical Immunology ◽

10.1016/j.jaci.2017.12.851 ◽

2018 ◽

Vol 141 (2) ◽

pp. AB268

Author(s):

Kenneth Paris ◽

Iftikhar Hussain ◽

Sudhir Gupta ◽

Ping Wang ◽

Barbara McCoy ◽

...

Keyword(s):

Immune Globulin ◽

Primary Immunodeficiency ◽

Pediatric Patients ◽

Primary Immunodeficiency Diseases ◽

Immunodeficiency Diseases ◽

Human Immune

Download Full-text

P251 Safety/tolerability of human immune globulin subcutaneous, 20% in pediatric patients with primary immunodeficiency diseases

Annals of Allergy Asthma & Immunology ◽

10.1016/j.anai.2016.09.264 ◽

2016 ◽

Vol 117 (5) ◽

pp. S97

Author(s):

K. Paris ◽

B. Dérfalvi ◽

I. Hussain ◽

E. Haddad ◽

F. Dicso ◽

...

Keyword(s):

Immune Globulin ◽

Primary Immunodeficiency ◽

Pediatric Patients ◽

Primary Immunodeficiency Diseases ◽

Immunodeficiency Diseases ◽

Human Immune

Download Full-text

Infusion Parameters and Adverse Events in Patients With Primary Immunodeficiency Diseases Who Switched to Subcutaneous Human Immune Globulin 20% (Ig20Gly) From Intravenous or Subcutaneous Immune Globulin

Journal of Allergy and Clinical Immunology ◽

10.1016/j.jaci.2017.12.850 ◽

2018 ◽

Vol 141 (2) ◽

pp. AB267

Author(s):

Iftikhar Hussain ◽

Kenneth Paris ◽

Amy Darter ◽

Lisa J. Kobrynski ◽

Todd Berner ◽

...

Keyword(s):

Adverse Events ◽

Immune Globulin ◽

Primary Immunodeficiency ◽

Primary Immunodeficiency Diseases ◽

Immunodeficiency Diseases ◽

Human Immune

Download Full-text

O015 Tolerability of a new human immune globulin subcutaneous, 20% preparation in primary immunodeficiency diseases

Annals of Allergy Asthma & Immunology ◽

10.1016/j.anai.2016.09.375 ◽

2016 ◽

Vol 117 (5) ◽

pp. S5-S6

Author(s):

S. Gupta ◽

M. Stein ◽

I. Melamed ◽

I. Hussain ◽

K. Paris ◽

...

Keyword(s):

Immune Globulin ◽

Primary Immunodeficiency ◽

Primary Immunodeficiency Diseases ◽

Immunodeficiency Diseases ◽

Human Immune

Download Full-text

SAFETY AND TOLERABILITY OF HUMAN IMMUNE GLOBULIN SUBCUTANEOUS, 20% (SCIG 20%) IN PATIENTS WITH PRIMARY IMMUNODEFICIENCY DISEASES (PIDD) IN EUROPE AND NORTH AMERICA

10.26226/morressier.57bc1758d462b80290b4cfef ◽

2016 ◽

Author(s):

L. Yel

Keyword(s):

North America ◽

Immune Globulin ◽

Primary Immunodeficiency ◽

Primary Immunodeficiency Diseases ◽

Immunodeficiency Diseases ◽

Human Immune

Download Full-text

Efficacy, Safety, and Pharmacokinetics of a Novel Human Immune Globulin Subcutaneous, 20 % in Patients with Primary Immunodeficiency Diseases in North America

Journal of Clinical Immunology ◽

10.1007/s10875-016-0327-9 ◽

2016 ◽

Vol 36 (7) ◽

pp. 700-712 ◽

Cited By ~ 23

Author(s):

Daniel Suez ◽

Mark Stein ◽

Sudhir Gupta ◽

Iftikhar Hussain ◽

Isaac Melamed ◽

...

Keyword(s):

North America ◽

Immune Globulin ◽

Primary Immunodeficiency ◽

Primary Immunodeficiency Diseases ◽

Immunodeficiency Diseases ◽

Human Immune

Download Full-text

Onboarding Experience of Patients With Primary Immunodeficiency Diseases Who Switched to Subcutaneous Human Immune Globulin 20% (Ig20Gly) From Intravenous or Subcutaneous Immune Globulin 10%

Journal of Allergy and Clinical Immunology ◽

10.1016/j.jaci.2017.12.081 ◽

2018 ◽

Vol 141 (2) ◽

pp. AB26

Author(s):

Sudhir Gupta ◽

Iftikhar Hussain ◽

Kenneth Paris ◽

Mark Stein ◽

Barbara McCoy ◽

...

Keyword(s):

Immune Globulin ◽

Primary Immunodeficiency ◽

Primary Immunodeficiency Diseases ◽

Immunodeficiency Diseases ◽

Human Immune

Download Full-text

ADVERSE EVENTS (AES) AND TOLERABILITY OF THE NEW HUMAN SUBCUTANEOUS IMMUNOGLOBULIN (SCIG 20%) IN PEDIATRIC PATIENTS (<18 YEARS OLD) WITH PRIMARY IMMUNODEFICIENCY DISEASES (PID)

10.26226/morressier.594a7d48d462b8028d8938c9 ◽

2017 ◽

Author(s):

Kim Haines

Keyword(s):

Adverse Events ◽

Primary Immunodeficiency ◽

Pediatric Patients ◽

Subcutaneous Immunoglobulin ◽

Primary Immunodeficiency Diseases ◽

Immunodeficiency Diseases

Download Full-text

Skin manifestations in pediatric patients with primary immunodeficiency diseases (PIDs) in a tertiary care hospital in Colombia

World Allergy Organization Journal ◽

10.1016/j.waojou.2021.100527 ◽

2021 ◽

Vol 14 (3) ◽

pp. 100527

Author(s):

William López-Quintero ◽

Daniela Cleves ◽

Jose David Gomez-Vasco ◽

Paola Pérez ◽

Jaime Patiño ◽

...

Keyword(s):

Primary Immunodeficiency ◽

Pediatric Patients ◽

Tertiary Care Hospital ◽

Tertiary Care ◽

Care Hospital ◽

Primary Immunodeficiency Diseases ◽

Immunodeficiency Diseases ◽

Skin Manifestations

Download Full-text

Long term use of intravenous immune globulin in patients with primary immunodeficiency diseases: Inadequacy of current dosage practices and approaches to the problem

Journal of Clinical Immunology ◽

10.1007/bf00918362 ◽

1982 ◽

Vol 2 (S2) ◽

pp. 15S-21S ◽

Cited By ~ 40

Author(s):

Rebecca H. Buckley

Keyword(s):

Immune Globulin ◽

Primary Immunodeficiency ◽

Intravenous Immune Globulin ◽

Primary Immunodeficiency Diseases ◽

Immunodeficiency Diseases

Download Full-text